Jennifer Jones is recognised as a go-to name for life sciences patent litigation including European-wide matters in the pharmaceutical and genetics fields.
Jenny is an experienced litigator of complex patent disputes in the life sciences sector. Jenny is a partner in Bird & Bird’s intellectual property group based in London.
She focuses primarily on pan-European patent litigation and oppositions within the life sciences sector, including pharmaceuticals, biologics, medical devices, and agricultural biotechnology. Within these industries, she represents clients before the UK Patents Court, in LCIA arbitration, mediation and oppositions at the European Patent Office.
Jenny began her career at the leading Canadian IP firm of Bereskin & Parr in Toronto. She holds an MSc in molecular biology and genetics from the University of British Columbia, a law degree from Dalhousie University and an LLM from the University of Cambridge. Jenny's science thesis was in agricultural biotechnology, using molecular biology techniques to elucidate the flavonoid pathway in plants. Her legal thesis considered the justiciability of copyright infringement claims.
Jenny recently co-authored a chapter on the protection of pharmaceuticals in Europe published by the American Bar Association. She is currently a member of the UK chapter of the International Association of Intellectual Property, the American Intellectual Property Law Association and the Intellectual Property Institute of Canada.
Jenny is recognised as a patent expert in the recent edition of Who's Who Legal: Patents.